Camlin Fine Sciences Promoter Declares No Share Encumbrance for FY26
Infinity Portfolio Holdings, the promoter of Camlin Fine Sciences Ltd., has submitted a regulatory declaration confirming no encumbrance on company shares for the financial year ended March 31, 2026. The declaration was filed pursuant to SEBI Regulation 31(4) and submitted to NSE, BSE, and company officials, maintaining compliance with transparency requirements.

*this image is generated using AI for illustrative purposes only.
Infinity Portfolio Holdings, the promoter of Camlin Fine Sciences Ltd., has submitted a regulatory declaration confirming no encumbrance on the company's shares for the financial year ended March 31, 2026. The declaration was filed on April 02, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Regulatory Declaration Details
The declaration was submitted pursuant to Regulation 31(4) of the SEBI Takeover Regulations by Infinity Portfolio Holdings, which operates through Vistra Alternative Investments (Mauritius) Limited. The document confirms that the promoter has not created any encumbrance on shares held directly or indirectly, beyond those previously disclosed.
| Parameter: | Details |
|---|---|
| Declaration Date: | April 02, 2026 |
| Financial Year: | Ended March 31, 2026 |
| Regulation: | SEBI Regulation 31(4) |
| Promoter Entity: | Infinity Portfolio Holdings |
| Signatory: | Shewinrao Ladkoo, Director |
| Operating Address: | Vistra Alternative Investments (Mauritius) Limited |
Compliance and Disclosure
The declaration was simultaneously submitted to multiple regulatory bodies and company officials to ensure comprehensive compliance. The promoter entity confirmed that no new encumbrances were created on company shares during the specified financial year, maintaining transparency in shareholding patterns. The document was signed by Shewinrao Ladkoo, Director, from the Ebene, Mauritius office.
Submission Recipients
The regulatory filing was addressed to multiple stakeholders as part of standard compliance requirements:
| Recipient: | Details |
|---|---|
| NSE: | National Stock Exchange of India Ltd. (Symbol: CAMLINFINE) |
| BSE: | BSE Limited (Scrip Code: 532834) |
| Internal: | Audit Committee of Camlin Fine Sciences Ltd. |
| Company: | Company Secretary of Camlin Fine Sciences Ltd. |
This declaration represents standard regulatory compliance for promoter entities, ensuring stakeholders remain informed about any changes in share encumbrance status. The submission maintains the company's adherence to SEBI's transparency requirements under the takeover regulations.
Historical Stock Returns for Camlin Fine Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.32% | +18.62% | +20.14% | -36.95% | -22.16% | -17.27% |
Will Infinity Portfolio Holdings consider increasing its stake in Camlin Fine Sciences now that shares remain unencumbered?
How might this clean shareholding status impact Camlin Fine Sciences' ability to attract new strategic investors or partnerships?
Could the unencumbered share status signal potential corporate restructuring or divestment plans by the promoter group?


































